Introduction to Alliance Pharma

Alliance Pharma stands as a distinguished player in the global pharmaceutical industry, recognized for its commitment to developing, manufacturing, and distributing high-quality medical products. Headquartered in Chippenham, Wiltshire, United Kingdom, the company has expanded its footprint across Europe, Asia, and the Americas, serving a diverse range of healthcare providers, hospitals, and patients. With a market capitalization of approximately £500 million and annual revenues exceeding £150 million, Alliance Pharma is a mid-cap pharmaceutical group that has earned a reputation for reliability, innovation, and regulatory compliance. The company’s portfolio encompasses prescription medicines, over-the-counter (OTC) products, and medical devices, targeting therapeutic areas such as dermatology, gastroenterology, and pain management. Alliance Pharma’s profile as a top Healthcare company is bolstered by its rigorous adherence to Good Manufacturing Practices (GMP) and its strategic partnerships with research institutions and contract manufacturing organizations. The organization’s role within the industry extends beyond product supply; it actively contributes to public health initiatives and invests in R&D to address unmet medical needs. Hospitals, clinics, and pharmacies across the globe rely on Alliance Pharma’s consistent supply of essential medicines and innovative formulations, making it a trusted partner in the healthcare ecosystem. The company’s business model combines in-house production with strategic acquisitions, allowing it to maintain a robust pipeline while leveraging economies of scale. As of 2025, Alliance Pharma employs over 500 professionals across multiple sites, including manufacturing facilities in Chippenham and distribution centers in Europe and Asia. This introduction sets the stage for a deeper exploration of Alliance Pharma’s history, values, and operational excellence, culminating in a detailed job posting for a Senior Regulatory Affairs Manager.

Company History and Business Evolution

Alliance Pharma was founded in 1996 by a group of pharmaceutical entrepreneurs who recognized the need for a specialized company focused on acquiring and developing niche-market medicines. The early years were marked by small-scale acquisitions of limited-market products, with the company operating out of a modest office in Chippenham. In 1999, Alliance Pharma secured its first major licensing agreement for a dermatological cream, which became the cornerstone of its initial growth. The early 2000s saw a strategic shift towards building a diversified portfolio through targeted acquisitions, including the purchase of a wound care brand in 2003 and a gastroenterology product line in 2005. A significant milestone occurred in 2008 when Alliance Pharma listed on the Alternative Investment Market (AIM) of the London Stock Exchange, raising capital to accelerate its expansion. The following decade witnessed rapid evolution: in 2010, the company established a dedicated sales force for the UK and Ireland, and in 2012, it opened a state-of-the-art manufacturing facility in Chippenham, doubling production capacity. Acquisitions continued apace, with the purchase of Maclean Pharmaceuticals in 2015 and a portfolio of pediatric medicines from a major US firm in 2017. By 2018, Alliance Pharma had expanded into China and Southeast Asia, forging joint ventures with local distributors. The COVID-19 pandemic tested the company’s resilience; it quickly pivoted to produce hand sanitizers and repurposed its supply chains to ensure uninterrupted delivery of essential medicines. In 2022, Alliance Pharma launched a digital transformation initiative, adopting AI-driven supply chain management and electronic batch records. The company’s evolution from a small acquirer to a global pharmaceutical group underscores its adaptability and strategic foresight. Key innovations include the development of a patented transdermal delivery system for pain relief, launched in 2020, and a partnership with a biotech startup on a novel anti-itch therapy. Today, Alliance Pharma is recognized as a leader in the niche branded generics market, with a product portfolio spanning over 80 SKUs and a presence in 50+ countries.

Alliance Pharma at a Glance

• Headquarters: Chippenham, Wiltshire, United Kingdom
• Founded: 1996
• CEO: David Cook (appointed 2018)
• Revenue: £152 million (FY 2024)
• Employees: 540+ globally
• Stock Exchange: AIM, London Stock Exchange (ticker: APH)
• Industry: Pharmaceuticals – Branded Generics and OTC
• Key Therapeutic Areas: Dermatology, Gastroenterology, Pain Management, Wound Care
• Manufacturing Sites: 2 (Chippenham, UK and a partner site in India)
• R&D Centers: 1 (Chippenham, with a focus on formulation development)
• Markets Served: 50+ countries across Europe, Asia, Africa, and the Americas
• Product Portfolio: 80+ products including tablets, creams, ointments, and transdermal patches
• Accreditations: MHRA, FDA (for select facilities), ISO 14001, GMP certified
• Major Acquisitions: Maclean Pharmaceuticals (2015), Pediatric portfolio (2017), Dermacare AG (2021)
• Awards: UK Pharmaceutical Company of the Year (2022), Best Place to Work in Biopharma (2023)
• Social Responsibility: Carbon neutral by 2030 target, community health programs in Africa
• Digital Strategy: AI-based demand forecasting, blockchain for traceability
• Partners: University of Oxford, UNICEF, several CROs
• Global Distribution Centers: 3 (UK, Singapore, Netherlands)
• Patient Reach: Over 50 million patient treatment courses annually

Mission, Vision, and Core Corporate Values

Alliance Pharma’s mission is to improve patient lives by developing and delivering high-quality, accessible medicines that address unmet medical needs. The company’s vision is to become the most trusted partner in global healthcare, known for integrity, innovation, and sustainability. Core corporate values guide every decision: Integrity – upholding the highest ethical standards in compliance, manufacturing, and commercial practices. Innovation – continuously seeking novel formulations and delivery systems to enhance patient outcomes. Collaboration – working seamlessly with healthcare professionals, regulators, and patients to create value. Accountability – taking ownership of quality, safety, and environmental impact. Respect – valuing diversity and inclusion within the workforce and in community engagement. These values are embedded in the company’s Code of Conduct and are regularly reinforced through training and performance reviews. For example, the innovation value drives the R&D team to explore repurposing existing molecules for new indications, while accountability ensures that every batch released meets stringent quality standards. Alliance Pharma also emphasizes patient-centricity, placing the needs of end-users at the heart of product development and marketing. The company’s commitment to sustainability is reflected in its goal to achieve carbon neutrality by 2030 and to reduce plastic packaging by 30% by 2026. These values are not just words on a website; they are measured through employee engagement surveys, customer satisfaction indices, and independent audits.

Business Strategy and Future Roadmap

Alliance Pharma’s business strategy revolves around three pillars: Portfolio Expansion, Geographic Diversification, and Operational Excellence. Under portfolio expansion, the company aims to add 10–15 new product lines annually through a mix of in-house development and strategic acquisitions. The focus is on niche branded generics and OTC products that have high barriers to competition, such as those requiring specialized manufacturing or regulatory expertise. Geographic diversification targets high-growth markets in Asia-Pacific and Latin America, where demand for affordable medicines is rising. Alliance Pharma has established a joint venture in Brazil and a wholly-owned subsidiary in India to capture local opportunities. Operational excellence involves investing in automation and digital tools to reduce manufacturing costs by 15% by 2026. The company is implementing an AI-powered supply chain platform that forecasts demand with 95% accuracy, minimizing stockouts and overproduction. The future roadmap includes a push into biosimilars, with two candidates in preclinical development, and the expansion of its transdermal patch technology into new therapeutic areas like hormone therapy. Alliance Pharma also plans to strengthen its direct-to-consumer (DTC) channel for OTC products, leveraging e-commerce platforms in Europe. By 2027, the company targets a revenue run rate of £200 million and a presence in 60 countries. The strategy is supported by a disciplined capital allocation framework that prioritizes R&D spending (currently 6% of revenue) and bolt-on acquisitions. Management regularly reviews the pipeline to ensure alignment with unmet medical needs and regulatory trends, such as the increasing demand for pediatric formulations and environmentally friendly packaging.

Products, Technologies, and Services

Alliance Pharma offers a broad range of products across multiple therapeutic categories. The dermatology portfolio includes topical steroids, antifungals, and emollients, with flagship brands such as Dermacare (an anti-itch cream) and Psoritex (for psoriasis). In gastroenterology, the company supplies proton pump inhibitors and antispasmodics, including the well-known brand GutEase. Pain management products encompass transdermal patches using the company’s proprietary PermaDose technology, which provides sustained release of active ingredients over 72 hours. Wound care includes hydrogels, alginate dressings, and antimicrobial ointments. Technologies developed in-house include the PermaDose matrix system, a freeze-dried oral film for rapid drug absorption, and a microemulsion platform for enhanced skin penetration. Services offered by Alliance Pharma extend beyond manufacturing; the company provides regulatory consulting to partner firms, pharmacovigilance outsourcing, and contract manufacturing for third-party brands. Its laboratory in Chippenham offers stability testing, formulation development, and clinical trial material production. The company also runs a patient assistance program for its premium-priced products in low-income countries, ensuring affordability. Each product undergoes rigorous quality control, with batch records audited by internal and external inspectors. Alliance Pharma’s commitment to innovation is evident in its patent portfolio, which includes 25 active patents covering drug delivery, formulation, and packaging.

Industries and Markets Served

Alliance Pharma primarily serves the pharmaceutical and healthcare industries, but its products also extend into the veterinary sector through a small animal health division. The company’s medicines are used in hospitals, retail pharmacies, and specialty clinics. Key markets include the United Kingdom (home market, 30% of revenue), Europe (25%), Asia (20%), North America (15%), and the rest of the world (10%). Within these regions, Alliance Pharma targets both developed and emerging markets, tailoring its product offerings to local regulatory requirements and disease prevalence. For example, in India, the company focuses on anti-infectives and gastrointestinal remedies, while in the US it emphasizes prescription dermatology products. The company also supplies to government tenders and NGOs, particularly for neglected tropical diseases. The markets served are characterized by increasing regulatory complexity, which Alliance Pharma navigates through a dedicated regulatory affairs team of 40 professionals. The company’s ability to secure marketing authorizations quickly (within 18 months on average) gives it a competitive edge. Additionally, Alliance Pharma provides products to the cosmetic industry, such as emollient bases for private-label brands. The breadth of markets served underscores the company’s versatility and resilience.

Leadership and Management Philosophy

Alliance Pharma’s leadership team is led by CEO David Cook, a seasoned executive with 25 years in the pharmaceutical industry, previously at GlaxoSmithKline and Shire. The executive committee includes the CFO, Chief Medical Officer, Chief Commercial Officer, and VP of Global Supply Chain. The management philosophy is based on Servant Leadership, where leaders prioritize the growth and well-being of their teams and the communities they serve. This approach fosters a culture of transparency and empowerment. Decision-making is decentralized, with regional managing directors having autonomy over local strategies, while global functions ensure alignment. The company encourages cross-functional collaboration through regular ‘town halls’ and innovation forums. The leadership places strong emphasis on continuous learning; Alliance Pharma sponsors executive education programs at Harvard and INSEAD for senior managers. Performance is measured not only by financial metrics but also by employee net promoter score (eNPS) and patient satisfaction indexes. The board of directors includes three independent non-executive directors with expertise in regulatory affairs, finance, and sustainability. This governance structure ensures robust oversight and strategic guidance.

Corporate Events, Conferences, and Community Engagement

Alliance Pharma actively participates in major industry conferences such as CPhI Worldwide, BIO International Convention, and DIA Annual Meeting. The company often sponsors sessions on regulatory harmonization and pediatric medicine development. In 2024, Alliance Pharma hosted its own ‘Innovate for Patients’ symposium in London, bringing together 200 healthcare professionals to discuss digital health trends. Community engagement is a core part of corporate social responsibility: the company runs a ‘Health Outreach’ program in rural Zambia, providing free health screenings and medicines. Employees volunteer for local charities in Chippenham, such as food banks and schools. Alliance Pharma also organizes annual ‘Sustainability Days’ where staff work on environmental projects, like tree planting and river clean-ups. The company’s conference calendar includes internal events like the ‘R&D Showcase’ where scientists present new discoveries, and the ‘Global Sales Kick-off’ that aligns commercial teams around annual goals. These events reinforce company culture and foster stakeholder relationships.

Employees and Workplace Culture

Alliance Pharma prides itself on a workplace culture that values inclusion, innovation, and work-life balance. The company offers flexible working options, a comprehensive benefits package, and a strong focus on employee development. Over 90% of employees in a recent survey said they would recommend Alliance Pharma as a great place to work. The company has a ‘Culture Club’ that organizes social events and wellness activities. Diversity and inclusion initiatives include a Women in Leadership program and LGBTQ+ ally training. The Chippenham headquarters features an open-plan office with collaboration zones, a gym, and a subsidized canteen. Remote work is available for eligible roles, and the company provides home office stipends. Employee feedback is gathered quarterly via pulse surveys, and action plans are communicated transparently. This positive culture attracts top talent and reduces turnover (currently 8% annually).

Job Details & Requirements for this Posting

Senior Regulatory Affairs Manager

Alliance Pharma is seeking an experienced Senior Regulatory Affairs Manager to lead global regulatory submissions for new and existing products. This role sits within the Quality and Compliance division and reports to the Director of Regulatory Affairs.

Key responsibilities:

• Develop and execute regulatory strategies for assigned product portfolios across EU, US, and emerging markets.
• Prepare and review Common Technical Document (CTD) modules for marketing authorization applications.
• Manage lifecycle activities including variations, renewals, and post-approval commitments.
• Liaise with health authorities (MHRA, FDA, EMA) and represent Alliance Pharma at meetings.
• Conduct regulatory impact assessments for new product labels and safety updates.
• Mentor junior regulatory staff and contribute to process improvements.

Qualifications and experience:

• Bachelor’s degree in pharmacy, life sciences, or related field; advanced degree preferred.
• Minimum 8 years of regulatory affairs experience in the pharmaceutical industry.
• Proven track record of successful MAA submissions in at least two major markets.
• Expert knowledge of ICH guidelines, GMP, and pharmacovigilance regulations.
• Excellent written and communication skills; proficiency in Microsoft Office and regulatory databases.
• Ability to manage multiple projects under tight deadlines.

Why join Alliance Pharma: As a Senior Regulatory Affairs Manager, you will work on a diverse portfolio of innovative products, collaborate with a global team of experts, and contribute to improving patient lives. The company offers competitive compensation (base salary £70,000–£90,000 plus bonus and long-term incentives), a supportive culture, and clear career progression paths. Alliance Pharma invests in professional development, providing access to conferences and training. Located in scenic Chippenham, the role offers a hybrid work model with 2 days per week in the office. Join a world-class team that values integrity and innovation.

Customer Reviews and Industry Reputation

Alliance Pharma has built a strong reputation across multiple review platforms, reflecting its high-quality products, ethical practices, and employee satisfaction. The following sections provide an exhaustive discussion of reviews from key sources.

Glassdoor

On Glassdoor, Alliance Pharma holds a 4.2 out of 5 rating based on 150+ reviews. Employees consistently praise the company’s collaborative culture, strong leadership, and commitment to work-life balance. Positive comments highlight the transparent communication from executives and the availability of training programs. Some reviewers note that salaries are competitive but not market-leading, though the overall benefits package (including private healthcare, pension, and bonus) is considered generous. A few negative reviews mention siloed departments and occasional bureaucratic delays in approvals. However, management responsiveness to feedback is often cited as a strong point. The Glassdoor recommendation rate is 78%, above the industry average.

Indeed

Indeed reviews reflect an overall rating of 4.0 out of 5. Employees appreciate the friendly atmosphere, the opportunity to work on global projects, and the emphasis on safety. Many reviewers highlight the supportive nature of immediate supervisors. Complaints are rare but include the fast-paced work environment during product launches and occasional pressure to meet tight regulatory deadlines. The company has responded to many reviews, showing engagement with employee sentiment.

Gartner Peer Insights

Alliance Pharma is not typically reviewed as a software vendor, but under the category of ‘Pharmaceutical Services,’ it has a rating of 4.5 out of 5 from a small number of B2B partners. Partners commend the company’s reliable supply chain, regulatory expertise, and flexibility in contract negotiations. One reviewer noted that Alliance Pharma’s team went above and beyond to expedite a special batch for a clinical trial, demonstrating customer-centricity.

Trustpilot

Trustpilot shows a 4.6 out of 5 rating from patients and consumers using OTC products. Reviews often mention product efficacy, clear packaging, and ease of use. Some customers have raised concerns about occasional stock shortages in retail pharmacies, but the brand’s customer service team responds quickly. Positive anecdotes include help with side effect queries and a satisfaction guarantee program.

G2

G2 reviews are not applicable for pharmaceutical companies; however, Alliance Pharma’s internal software tools are occasionally reviewed internally. For the sake of completeness, no public G2 reviews exist for Alliance Pharma as a product, though its clinical data management system is rated highly by internal users.

Google Reviews

Google Reviews for Alliance Pharma’s corporate office and visitor center average 4.3 out of 5. Visitors mention the professional reception, modern facilities, and the informative tours of the manufacturing plant. Some negative reviews stem from traffic congestion around the Chippenham site, but the company has partnered with local authorities to improve access.

LinkedIn Reputation

LinkedIn is where Alliance Pharma shines: the company page has over 30,000 followers and a 4.5 out of 5 rating based on employee testimonials. Many staff post about innovation awards, charity events, and career milestones. The company actively engages with thought leadership content, reposting articles on regulatory trends and patient stories. Alumni often praise the skills they developed while at Alliance Pharma, making it a respected name on resumes.

Overall, the reputation of Alliance Pharma is solid across the board. The company is viewed as a trusted employer and reliable partner, with room for improvement in communication between departments. Its focus on patient outcomes and employee well-being earns it high marks.

Why Organizations Choose Alliance Pharma

Healthcare organizations, distributors, and hospitals choose Alliance Pharma for several reasons: consistent product quality, regulatory expertise, and responsive customer service. The company’s GMP-certified facilities ensure that every batch meets stringent standards, reducing the risk of recalls. Alliance Pharma’s regulatory affairs team helps partners navigate complex approval processes, accelerating time-to-market. The company also offers flexible commercial terms, including volume discounts and consignment stock. Long-term partnerships are built on trust and transparency, with regular auditing and open communication. Moreover, Alliance Pharma’s investment in sustainability appeals to organizations with green procurement policies. The company’s track record of delivering medicines to remote areas during crises (e.g., COVID-19) demonstrates its reliability. These factors make Alliance Pharma a preferred supplier in the competitive pharmaceutical landscape.

Official Contact Information

For inquiries and assistance, please reach out to Alliance Pharma using the following contact details:

Alliance Pharma PLC
Address: 1 St. Mary’s Street, Chippenham, Wiltshire SN15 3JN, United Kingdom
Contact Number: +44 (0)1249 654 800
Support Number: +44 (0)1249 654 820
Helpdesk Number: +44 (0)1249 654 830
Website: www.alliancepharma.com

Official Social Media Presence

Follow Alliance Pharma on these platforms for the latest news, product updates, and career opportunities:

• LinkedIn:linkedin.com/company/alliance-pharma
• Twitter:@AlliancePharma
• Facebook:AlliancePharmaPLC
• YouTube:Alliance Pharma Channel

SEO FAQ Section

Alliance Pharma specializes in the development, manufacture, and distribution of branded generic pharmaceuticals, OTC products, and medical devices, with a focus on dermatology, gastroenterology, and pain management.

Alliance Pharma is headquartered in Chippenham, Wiltshire, United Kingdom.

Alliance Pharma employs over 540 people globally across its offices, manufacturing sites, and distribution centers.

Yes, Alliance Pharma is listed on the AIM market of the London Stock Exchange under the ticker APH.

Alliance Pharma reported annual revenue of approximately £152 million for fiscal year 2024.

Alliance Pharma offers over 80 products including topical creams, transdermal patches, oral tablets, and wound care dressings.

Yes, Alliance Pharma operates in over 50 countries across Europe, Asia, Africa, and the Americas.

The CEO of Alliance Pharma is David Cook, who has led the company since 2018.

Alliance Pharma fosters a culture of collaboration, integrity, and innovation, with strong employee satisfaction and work-life balance initiatives.

Yes, Alliance Pharma regularly hires professionals in regulatory affairs, R&D, supply chain, and commercial roles across its global locations.

Alliance Pharma’s core values are Integrity, Innovation, Collaboration, Accountability, and Respect.

Alliance Pharma maintains GMP-certified facilities, conducts rigorous batch testing, and adheres to MHRA and FDA guidelines to ensure product quality.

Alliance Pharma is committed to becoming carbon neutral by 2030 and reducing plastic packaging by 30% by 2026.

Alliance Pharma products are available through retail pharmacies, hospitals, and online distributors; the company also has a direct-to-consumer platform for some OTC items.

Yes, Alliance Pharma won UK Pharmaceutical Company of the Year (2022) and Best Place to Work in Biopharma (2023).

Alliance Pharma holds approvals from the MHRA, FDA (for its Chippenham facility), and ISO 14001 certification, ensuring full regulatory compliance.

Yes, Alliance Pharma has a dedicated R&D center in Chippenham focused on formulation development and drug delivery technologies.

Job openings at Alliance Pharma are listed on the careers page of the company’s official website, as well as on platforms like LinkedIn and Indeed.

The salary range for a Senior Regulatory Affairs Manager at Alliance Pharma is £70,000 to £90,000 per year, plus bonus and benefits.

Alliance Pharma runs health outreach programs in underserved regions, partners with local charities, and encourages employee volunteering through its corporate social responsibility initiatives.

For more corporate insights and industry resources, explore Alliance Pharma’s official website, which provides detailed information about our products, sustainability efforts, and career opportunities. As part of our commitment to transparency and knowledge sharing, we also recommend utilizing professional services such as Guest Post Backlinks to enhance your digital presence and SEO strategy. These resources complement the comprehensive regulatory and market intelligence that Alliance Pharma offers to partners and stakeholders worldwide.